{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T12:24:58Z","timestamp":1710332698969},"reference-count":79,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2014.00068","type":"journal-article","created":{"date-parts":[[2014,7,2]],"date-time":"2014-07-02T01:21:07Z","timestamp":1404264067000},"source":"Crossref","is-referenced-by-count":7,"title":["An Emerging Molecular Understanding and Novel Targeted Treatment Approaches in Pediatric Kidney Diseases"],"prefix":"10.3389","volume":"2","author":[{"given":"Max Christoph","family":"Liebau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2014,7,1]]},"reference":[{"issue":"8","key":"B1","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrneph.2012.115","article-title":"Childhood nephrotic syndrome \u00e2\u20ac\u201c current and future therapies","volume":"8","author":"Greenbaum","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"B2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nrneph.2013.78","article-title":"The role of the podocyte in albumin filtration","volume":"9","author":"Brinkkoetter","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1084\/jem.113.1.47","article-title":"Glomerular permeability. I. Ferritin transfer across the normal glomerular capillary wall","volume":"113","author":"Farquhar","year":"1961","journal-title":"J Exp Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1084\/jem.114.5.699","article-title":"Glomerular permeability. II. Ferritin transfer across the glomerular capillary wall in nephrotic rats","volume":"114","author":"Farquhar","year":"1961","journal-title":"J Exp Med"},{"issue":"6","key":"B5","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1084\/jem.124.6.1123","article-title":"Glomerular permeability. Ultrastructural cytochemical studies using peroxidases as protein tracers","volume":"124","author":"Graham","year":"1966","journal-title":"J Exp Med"},{"issue":"4","key":"B6","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/S1097-2765(00)80057-X","article-title":"Positionally cloned gene for a novel glomerular protein \u00e2\u20ac\u201c nephrin \u00e2\u20ac\u201c is mutated in congenital nephrotic syndrome","volume":"1","author":"Kestil\u00c3\u00a4","year":"1998","journal-title":"Mol Cell"},{"issue":"14","key":"B7","doi-asserted-by":"publisher","first-page":"7962","DOI":"10.1073\/pnas.96.14.7962","article-title":"Nephrin is specifically located at the slit diaphragm of glomerular podocytes","volume":"96","author":"Ruotsalainen","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"B8","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s00467-012-2239-0","article-title":"New developments in steroid-resistant nephrotic syndrome","volume":"28","author":"Saleem","year":"2013","journal-title":"Pediatr Nephrol"},{"issue":"19","key":"B9","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1055\/s-0031-1275836","article-title":"[Recent developments in genetic kidney diseases]","volume":"136","author":"Liebau","year":"2011","journal-title":"Dtsch Med Wochenschr"},{"issue":"8","key":"B10","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nrneph.2013.109","article-title":"The glomerular basement membrane as a barrier to albumin","volume":"9","author":"Suh","year":"2013","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"B11","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1172\/JCI28414","article-title":"Proteinuria precedes podocyte abnormalities in Lamb2\u00e2\u02c6\u2019\/\u00e2\u02c6\u2019 mice, implicating the glomerular basement membrane as an albumin barrier","volume":"116","author":"Jarad","year":"2006","journal-title":"J Clin Invest"},{"issue":"12","key":"B12","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nrneph.2013.197","article-title":"The role of the glomerular endothelium in albumin handling","volume":"9","author":"Satchell","year":"2013","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"B13","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1172\/JCI17423","article-title":"Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases","volume":"111","author":"Eremina","year":"2003","journal-title":"J Clin Invest"},{"issue":"1","key":"B14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1681\/ASN.2008050493","article-title":"Pregnancy and the kidney","volume":"20","author":"Maynard","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"B15","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N Engl J Med"},{"issue":"7","key":"B16","doi-asserted-by":"publisher","first-page":"4108","DOI":"10.1073\/pnas.0730776100","article-title":"Why the kidney glomerulus does not clog: a gel permeation\/diffusion hypothesis of renal function","volume":"100","author":"Smithies","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"B17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/nrneph.2013.58","article-title":"Renal albumin filtration: alternative models to the standard physical barriers","volume":"9","author":"Moeller","year":"2013","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"B18","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1053\/j.ackd.2011.03.005","article-title":"Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients","volume":"18","author":"Kiffel","year":"2011","journal-title":"Adv Chronic Kidney Dis"},{"issue":"11","key":"B19","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.2215\/CJN.01190210","article-title":"Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome","volume":"5","author":"B\u00c3\u00bcscher","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"B20","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s00467-010-1468-3","article-title":"Successful treatment of steroid resistant nephrotic syndrome associated with WT1 mutations","volume":"25","author":"Gellermann","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"B21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/ki.2013.93","article-title":"Genetic screening in adolescents with steroid-resistant nephrotic syndrome","volume":"84","author":"Lipska","year":"2013","journal-title":"Kidney Int"},{"issue":"1 Suppl","key":"B22","doi-asserted-by":"publisher","first-page":"S128","DOI":"10.1097\/01.tp.0000187110.25512.82","article-title":"Recurrence of focal-segmental glomerulosclerosis in children after renal transplantation: clinical and genetic aspects","volume":"80","author":"Weber","year":"2005","journal-title":"Transplantation"},{"issue":"8","key":"B23","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/nm.2411","article-title":"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis","volume":"17","author":"Wei","year":"2011","journal-title":"Nat Med"},{"issue":"12","key":"B24","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1681\/ASN.2012030302","article-title":"Circulating suPAR in two cohorts of primary FSGS","volume":"23","author":"Wei","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"B25","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s00467-013-2452-5","article-title":"Serum suPAR in patients with FSGS: trash or treasure?","volume":"28","author":"Maas","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-014-2808-5","article-title":"Decreased glomerular filtration as the primary factor of elevated circulating suPAR levels in focal segmental glomerulosclerosis","author":"Harita","year":"2014","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"B27","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrneph.2012.195","article-title":"STEC-HUS, atypical HUS and TTP are all diseases of complement activation","volume":"8","author":"Noris","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"B28","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nrneph.2012.214","article-title":"French Study Group for aHUS\/C3G. Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies","volume":"8","author":"Zuber","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"B29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00467-010-1556-4","article-title":"aHUS caused by complement dysregulation: new therapies on the horizon","volume":"26","author":"Waters","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"B30","doi-asserted-by":"publisher","first-page":"e003573","DOI":"10.1136\/bmjopen-2013-003573","article-title":"A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)","volume":"3","author":"Rathbone","year":"2013","journal-title":"BMJ Open"},{"issue":"3","key":"B31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/MNH.0b013e328345848b","article-title":"Complement and glomerular disease: new insights","volume":"20","author":"Pickering","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"20","key":"B32","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1182\/blood-2010-07-271445","article-title":"How I treat patients with thrombotic thrombocytopenic purpura: 2010","volume":"116","author":"George","year":"2010","journal-title":"Blood"},{"issue":"4","key":"B33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/jca.20169","article-title":"Lessons learned from the Oklahoma thrombotic thrombocytopenic purpura-hemolytic uremic syndrome registry","volume":"23","author":"George","year":"2008","journal-title":"J Clin Apher"},{"issue":"10","key":"B34","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1016\/j.transproceed.2010.09.125","article-title":"Eculizumab: safety and efficacy after 17 months of treatment in a renal transplant patient with recurrent atypical hemolytic-uremic syndrome: case report","volume":"42","author":"Ch\u00c3\u00a2telet","year":"2010","journal-title":"Transplant Proc"},{"issue":"18","key":"B35","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1056\/NEJMc1001060","article-title":"Prophylactic eculizumab after renal transplantation in atypical hemolytic-uremic syndrome","volume":"362","author":"Zimmerhackl","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"B36","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/ki.2013.377","article-title":"C3 glomerulopathy: consensus report","volume":"84","author":"Pickering","year":"2013","journal-title":"Kidney Int"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-013-2559-8","article-title":"Making sense of the spectrum of glomerular disease associated with complement dysregulation","author":"Johnson","year":"2013","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"B38","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1056\/NEJMc1106619","article-title":"Eculizumab and refractory membranoproliferative glomerulonephritis","volume":"366","author":"Radhakrishnan","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"B39","doi-asserted-by":"publisher","first-page":"748","DOI":"10.2215\/CJN.12901211","article-title":"Eculizumab for dense deposit disease and C3 glomerulonephritis","volume":"7","author":"Bomback","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"B40","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/nrneph.2012.213","article-title":"Pathogenesis of the C3 glomerulopathies and reclassification of MPGN","volume":"8","author":"Bomback","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"14","key":"B41","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.molimm.2011.04.005","article-title":"Dense deposit disease","volume":"48","author":"Smith","year":"2011","journal-title":"Mol Immunol"},{"issue":"3","key":"B42","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1136\/jmg.2006.045328","article-title":"Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome","volume":"44","author":"Servais","year":"2007","journal-title":"J Med Genet"},{"issue":"26","key":"B43","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1056\/NEJMc1100859","article-title":"Eculizumab in severe Shiga-toxin-associated HUS","volume":"364","author":"Lapeyraque","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"B44","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/ndt\/gft470","article-title":"Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab","volume":"29","author":"Delmas","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"B45","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/cid\/cis531","article-title":"An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children","volume":"55","author":"Loos","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"10","key":"B46","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1093\/ndt\/gfs394","article-title":"Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin producing E. coli O104:H4 induced haemolytic-uraemic syndrome: an analysis of the German STEC-HUS registry","volume":"27","author":"Kielstein","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"16","key":"B47","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1056\/NEJMra1010172","article-title":"Ciliopathies","volume":"364","author":"Hildebrandt","year":"2011","journal-title":"N Engl J Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev.med.60.101707.125712","article-title":"Polycystic kidney disease","volume":"60","author":"Harris","year":"2009","journal-title":"Annu Rev Med"},{"issue":"9","key":"B49","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1007\/s00467-012-2370-y","article-title":"Looking at the (w)hole: magnet resonance imaging in polycystic kidney disease","volume":"28","author":"Liebau","year":"2013","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"B50","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2009.10.036","article-title":"Centrioles, centrosomes, and cilia in health and disease","volume":"139","author":"Nigg","year":"2009","journal-title":"Cell"},{"issue":"1","key":"B51","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cell.2009.03.023","article-title":"The vertebrate primary cilium in development, homeostasis, and disease","volume":"137","author":"Gerdes","year":"2009","journal-title":"Cell"},{"issue":"17","key":"B52","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0960-9822(01)00423-7","article-title":"The Caenorhabditis elegans autosomal dominant polycystic kidney disease gene homologs lov-1 and pkd-2 act in the same pathway","volume":"11","author":"Barr","year":"2001","journal-title":"Curr Biol"},{"issue":"3","key":"B53","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1083\/jcb.151.3.709","article-title":"Chlamydomonas IFT88 and its mouse homologue, polycystic kidney disease gene tg737, are required for assembly of cilia and flagella","volume":"151","author":"Pazour","year":"2000","journal-title":"J Cell Biol"},{"issue":"10","key":"B54","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1097\/01.ASN.0000141055.57643.E0","article-title":"Intraflagellar transport and cilia-dependent renal disease: the ciliary hypothesis of polycystic kidney disease","volume":"15","author":"Pazour","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"B55","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/ng1418","article-title":"Loss of BBS proteins causes anosmia in humans and defects in olfactory cilia structure and function in the mouse","volume":"36","author":"Kulaga","year":"2004","journal-title":"Nat Genet"},{"issue":"44","key":"B56","doi-asserted-by":"publisher","first-page":"17524","DOI":"10.1073\/pnas.0706618104","article-title":"Loss of Bardet Biedl syndrome proteins causes defects in peripheral sensory innervation and function","volume":"104","author":"Tan","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"B57","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2215\/CJN.00060108","article-title":"Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies","volume":"3","author":"Chapman","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"20","key":"B58","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"Volume progression in polycystic kidney disease","volume":"354","author":"Grantham","year":"2006","journal-title":"N Engl J Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2369-8-13","article-title":"Clinical proof-of-concept trial to assess the therapeutic effect of sirolimus in patients with autosomal dominant polycystic kidney disease: SUISSE ADPKD study","volume":"8","author":"Serra","year":"2007","journal-title":"BMC Nephrol"},{"issue":"9","key":"B60","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"Walz","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"B61","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"B62","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1056\/NEJMe1006925","article-title":"mTOR inhibitors in polycystic kidney disease","volume":"363","author":"Watnick","year":"2010","journal-title":"N Engl J Med"},{"issue":"14","key":"B63","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"B64","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1681\/ASN.2009040421","article-title":"Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1","volume":"21","author":"Shillingford","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"B65","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.2215\/CJN.01360210","article-title":"Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases","volume":"5","author":"Torres","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"B66","doi-asserted-by":"publisher","first-page":"e63506","DOI":"10.1371\/journal.pone.0063506","article-title":"Dysregulated autophagy contributes to podocyte damage in Fabry\u00e2\u20ac\u2122s disease","volume":"8","author":"Liebau","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"B67","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1172\/JCI44774","article-title":"Role of mTOR in podocyte function and diabetic nephropathy in humans and mice","volume":"121","author":"G\u00c3\u00b6del","year":"2011","journal-title":"J Clin Invest"},{"issue":"4","key":"B68","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1172\/JCI39492","article-title":"Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice","volume":"120","author":"Hartleben","year":"2010","journal-title":"J Clin Invest"},{"issue":"10","key":"B69","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1681\/ASN.2012040367","article-title":"Folate-conjugated rapamycin slows progression of polycystic kidney disease","volume":"23","author":"Shillingford","year":"2012","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"B70","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1681\/ASN.2004121090","article-title":"Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat","volume":"16","author":"Wang","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"B71","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nm1004","article-title":"Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease","volume":"10","author":"Torres","year":"2004","journal-title":"Nat Med"},{"issue":"25","key":"B72","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"B73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrneph.2012.236","article-title":"Polycystic kidney disease: tolvaptan in ADPKD-TEMPO 3:4 trial results","volume":"9","author":"Kelsey","year":"2013","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"B74","doi-asserted-by":"publisher","first-page":"382","DOI":"10.7326\/0003-4819-159-6-201309170-00004","article-title":"Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease","volume":"159","author":"Erickson","year":"2013","journal-title":"Ann Intern Med"},{"issue":"5","key":"B75","doi-asserted-by":"publisher","first-page":"783","DOI":"10.2215\/CJN.05380709","article-title":"Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotide","volume":"5","author":"Caroli","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"B76","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1111\/j.1523-1755.2005.00395.x","article-title":"Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease","volume":"68","author":"Ruggenenti","year":"2005","journal-title":"Kidney Int"},{"issue":"6","key":"B77","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1681\/ASN.2009121291","article-title":"Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease","volume":"21","author":"Hogan","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"B78","doi-asserted-by":"publisher","first-page":".e1","DOI":"10.1053\/j.gastro.2009.07.052","article-title":"Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial","volume":"137","author":"Van Keimpema","year":"2009","journal-title":"Gastroenterology"},{"issue":"9903","key":"B79","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0140-6736(13)61407-5","article-title":"Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial","volume":"382","author":"Caroli","year":"2013","journal-title":"Lancet"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"deposited":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T14:45:50Z","timestamp":1424270750000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fped.2014.00068\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,1]]},"references-count":79,"URL":"https:\/\/doi.org\/10.3389\/fped.2014.00068","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,1]]}}}